A solar charging kit, inexpensive as-is and purchased after further promotional enticement, enables keeping a remotely located vehicle battery topped off. One of the things I enjoy most about ...

Adding sodium-glucose cotransporter 2 (SGLT2) inhibitors to standard medical therapy for heart failure with preserved ejection fraction (HFpEF) provides just low-to-intermediate economic value to the ...

CKD screening at age 55, combined with SGLT2 inhibitors, reduces kidney failure incidence and improves life expectancy across racial and ethnic groups. Non-Hispanic Black adults experience the most ...

In education as in finance, a diverse portfolio can be the most sustainable investment. School District 11 in Colorado Springs hopes this kind of portfolio approach will enable it to continue to ...

Last month, the Institute for Clinical and Economic Review (ICER) issued a draft report on the cost-effectiveness of bluebird bio’s lovo-cel (lovotibeglogene autotemcel) and Vertex/CRISPR’s ...

This commentary argues that practitioners of cost-effectiveness analyses should incorporate dynamic drug pricing into formal cost-effectiveness analyses (CEAs). For reasons we discuss, doing so will ...

Receiving a notice from the Internal Revenue Service (IRS) about unpaid taxes can trigger feelings of fear, no matter what your original balance is. After all, the combination of the original tax ...

In my last blog, we discussed why increasing access to primary care is critical to improving individual patient and population health and reducing costs, as well as strategies for achieving it. In ...

Lifetime treatment with statins is a cost-effective therapy across a wide range of elderly patients with and without cardiovascular disease, according to an analysis published this week in Heart.

Several new treatment combinations have been approved in metastatic renal cell carcinoma (mRCC). To determine the optimal therapy on the basis of cost and health outcomes, we performed a ...